Furthermore, it is argued that while shorter blood telomere length is associated with higher age-related risks of VHL-associated central nervous system hemangioblastomas, renal cell carcinoma, pancreatic cysts, and neuroendocrine tumors, the correlation may not be consistent across all patients with VHL disease. Here, VHL is linked to renal cell carcinoma.